Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)

Poitiers University Hospital50 enrolled

Overview

Many cancers are diagnosed after 75 years. Treatment in chemotherapy begins without evidence of geriatric risk factors. A new tool for screening for geriatric fragilities is used, a self-administered questionnaire carried out by the patient before each chemotherapy cure. The objective is to secure the quality of patient care and to detect the appearance and / or aggravation of geriatric fragilities.

Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment: * Number of D-FOGs filled in: comparison with the number of patients included in the study and the number of visits of each patient. * Regularity of the D-FOG self-questionnaire by the patient: comparison with the number of visits of the patient for a chemotherapy cure (HDJ or HDS). * Number of criteria entered by D-FOG: comparison with the total number of criteria to be filled in * Criterion analysis of D-FOG

Study Type

OBSERVATIONAL

Enrollment

Conditions

75 Years Old and More Cancer Chemotherapy

Interventions

Self-questionnaireOTHER

Filling of a self-questionnaire before each chemotherapy cure

Eligibility

Sex: ALLMin age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients aged 75 years and over * Carriers of diagnosed cancer (excluding hematology) * Whatever the location, uniqueness or multiple, duration of development and treatment status (adjuvant, neoadjuvant, locally advanced or metastatic) * Seen in nursing consultant * Beginning an oncological treatment * Supported for oncology day hospital (HDJ) or weekly (HDS) chemotherapy * Patient not opposed to participate in the study Exclusion Criteria: * Patients under 75 years of age * Having not had an IDE ad consultation * During oncological treatment * Receiving Oral Therapy or hormone therapy alone * Treated by radiotherapy alone or surgery alone * Not attending a day or week oncology hospital * Refusal to participate in research

Locations (1)

CHU

Poitiers, France

Outcomes

Primary Outcomes

Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment.

Feasibility of D-FOG for patients : number of D-FOGs filled in, regularity of the D-FOG self-questionnaire by the patient, number of criteria entered by D-FOG, criterion analysis of D-FOG

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.